Share: Facebook Twitter GooglePLus LinkedIn
Activity Provided By:

University at Buffalo School of Pharmacy

"PCSK9 Inhibitors: An Overview of Cardiovascular Outcomes and Place in Therapy"

Access Activity

Overview / Abstract:

Live and Via Webinar

Learning Objectives:

• Describe the mechanism of PCSK9 inhibitors and their effects on lipids
• Review currently available literature regarding cardiovascular outcomes with evolocumab and alirocumab
• Discuss the current place in therapy for PCSK9 inhibitors and identify patients most likely to benefit from use

Target Audience:
Pharmacists in all practice settings.

Program components are:

Pre-test
Lecture
On-site post-test

Achieving a passing score of the assessment post-test is not a requirement of obtaining continuing education credit; however participating in all active learning components is.

Questions: Please email pharmacyce@buffalo.edu

Expiration

Mar 07, 2019

Discipline(s)

Pharmacy CPE

Format

Live / Seminar, Webinar / Webcast / Video

Cost

$25

Credits / Hours

1 contact hour, 0.1 ceus

Accreditation

ACPE

Is This Activity Certified for "Live" Credit?

YES

Presenters / Authors / Faculty

Hailey Lipinski, PharmD

PGY2 Ambulatory Care Pharmacy Resident

Buffalo Medical Group

Activity Specialities / Related Topics

Cardiology / Cardiovascular

Keywords / Search Terms

University at Buffalo School of Pharmacy Cardiology, lipid control, PCSK9 inhibitors, cardiovascular outcomes, evolocumab, alirocumab Live CE CME Seminar CE CME

LIVE Activity Location Details

Date(s)
03-06-2019

University at Buffalo School of Pharmacy and Pharmaceutical Sciences, 250 Kapoor Hall
250 Kapoor Hall
Buffalo, NY   14214
United States of America

Access Activity

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.